Jyong Biotech Ltd.
(NASDAQ: MENS)
Jyong Biotech Ltd. operates as a holding company, which engages in the development of biotechnology products. It offers plant-derived drugs that focus on the treatment of urinary system diseases. The company was founded by Fu Feng Kuo in July 2002 and is headquartered in New Taipei, Taiwan.
26.900
-2.290
(-7.85%)
Range
26.730 - 30.000
(12.23%)
Open
27.000
Previous Close
29.190
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
39,862
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis